Kalshi Launches Prediction Markets for Clinical Trials and FDA Decisions

Prediction market Kalshi and public intelligence company AppliedXL have launched a pilot program that allows trading on clinical trial outcomes and Food and Drug Administration (FDA) regulatory decisions. The companies said in a Thursday (July 16) press release that examples of the contracts available at launch include “Will AR1001’s POLARIS-AD Phase 3 trial meet its primary endpoint in early Alzheimer’s disease?” and “Will the FDA approve Gilead/Arcellx’s anito-cel for relapsed/refractory multi